These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10365132)

  • 1. Cadherins in renal cell carcinoma.
    Heicappell R
    Anticancer Res; 1999; 19(2C):1501-4. PubMed ID: 10365132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [E-cadherin expression and histopathological features in renal cell carcinomas].
    Jin TX; Kakehi Y; Moroi S; Yoshida O
    Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of cell adhesion in renal epithelium without cadherin loss.
    O'Donnell M; Fleming S
    J Pathol; 1995 Jan; 175(1):45-50. PubMed ID: 7891226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between E-cadherin and p27Kip1 expression in renal cell carcinoma.
    Migita T; Oda Y; Masuda K; Hirata A; Kuwano M; Naito S; Tsuneyoshi M
    Int J Oncol; 2008 Jul; 33(1):41-7. PubMed ID: 18575749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complex cadherins in cell-cell adhesion evaluated by spheroid formation in renal cell carcinoma cell lines.
    Shimazui T; Schalken JA; Kawai K; Kawamoto R; van Bockhoven A; Oosterwijk E; Akaza H
    Oncol Rep; 2004 Feb; 11(2):357-60. PubMed ID: 14719067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma.
    Fischer C; Georg C; Kraus S; Terpe HJ; Luedecke G; Weidner W
    Anticancer Res; 1999; 19(2C):1513-7. PubMed ID: 10365135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cadherins in malignancies of the female genital tract].
    Piura B; Rabinovich A; Aizenberg N; Wolfson M
    Harefuah; 2005 Apr; 144(4):261-5, 303, 302. PubMed ID: 15889610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal-cell carcinoma.
    Morell-Quadreny L; Rubio J; Lopez-Guerrero JA; Casanova J; Ramos D; Iborra I; Solsona E; Llombart-Bosch A
    Anticancer Res; 2003; 23(6D):5005-10. PubMed ID: 14981959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma.
    Horiguchi A; Asano T; Asakuma J; Asano T; Sumitomo M; Hayakawa M
    J Urol; 2004 Aug; 172(2):718-22. PubMed ID: 15247769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
    Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
    Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.